Navigation Links
lung in Biological Technology

Poniard Pharmaceuticals Reports Second Quarter 2009 Financial Results and Provides a Corporate Update

... Phase 3 SPEAR trial of picoplatin in small cell lung cancer in the fourth quarter of 2009 with the ... the pivotal Phase 3 SPEAR trial in small cell lung cancer (SCLC) in the fourth quarter of 2009; ... picoplatin include a Phase 3 trial in small cell lung cancer and Phase 2 trials in metastatic ...

Oncothyreon announces presentation of long-term Stimuvax data at World Conference on Lung Cancer

... at the International Association for the Study of lung Cancer's 13th World Conference on lung Cancer in San Francisco on August 1, 2009. The ... in patients with stage IIIb/IV non-small cell lung cancer (NSCLC). As of the time of data analysis ...

Transave Enters Into Cooperative Research Agreement With NIH To Study ARIKACE(TM) In Nontuberculous Mycobacteria

... patients with nontuberculous mycobacteria (NTM) lung infections. Transave and NIAID will ... trial to evaluate ARIKACE in patients with NTM lung disease who have failed to respond to standard, ... MD. "This is the third type of chronic lung infection for which ARIKACE is being evaluated," ...

New Report Just Published: World Prostate Cancer Therapeutics Market Report

... (2007): Percentage Breakdown by Cancer Type - lung & Bronchus, Prostate, Colon & Rectum, ... Immunotoxin for Treatment of Prostate and lung Cancer II-66 Barr Unveils Generic Version of ... (2007): Percentage Breakdown by Cancer Type - lung & Bronchus, Prostate, Colon & Rectum, ...

DOR BioPharma Announces Publication of orBec(R) Clinical Pulmonary Data in Bone Marrow Transplantation

... BDP) decreases non-infectious inflammation of the lung in acute gastrointestinal Graft-versus-Host ... (HCT). Non-infectious inflammation of the lung is a common and potentially fatal complication of ... exchange of oxygen and carbon dioxide between the lung and blood and, in its severe form, may present as ...

Helix BioPharma to Present L-DOS47 Analytical Method Development Findings at 2009 AAPS National Biotechnology Conference

... L-DOS47, a Novel Candidate for the Treatment of lung Adenocarcinoma" provides a summary of the ... of the lung, the most common form of lung cancer in the world today. L-DOS47 is thought to ... to modify the microenvironmental conditions of lung cancer cells in a manner that leads to their ...

Phase 3 Cystic Fibrosis Trial Results Presented at European Conference

... trial was to assess whether Bronchitol improves lung function as measured by a change in FEV1 when ... was to assess whether Bronchitol further improves lung function in patients already being treated with ... an immediate and sustained improvement in lung function (FEV1) over the 26 weeks ...

AEterna Zentaris Discloses Preliminary Phase 2 Trial Results for Perifosine in Combination with Radiotherapy for Non-Small Cell Lung Cancer

... multi-center Phase 2 trial in non-small cell lung cancer (NSCLC) with its novel, first-in-class, ... of clinical laboratory, electrocardiograms, lung function, and adverse events. The trial was ... colon cancer where, unlike the non-small cell lung cancer study design, perifosine is dosed 50mg or ...

Ascenta Therapeutics Announces Presentation of Promising Results From Clinical Trials of AT-101 in Prostate, Brain, and Lung Cancers at 2009 ASCO Annual Meeting

... ongoing clinical studies in prostate, brain and lung cancers were among the data presented on AT-101, ... primary endpoint, is ongoing. AT-101 in lung Cancer Reports from two studies in lung cancer also showed promising signals of antitumor ...

Oncothyreon announces clinical data from three product candidates presented at American Society of Clinical Oncology (ASCO) Annual Meeting

... in patients with stage IIIB/IV non-small cell lung cancer, preliminary results from the Phase 1 ... in patients with stage IIIb/IV non-small cell lung cancer (NSCLC) were studied. Ten of these ... MUC1 is over-expressed on many cancers such as lung cancer, breast cancer, prostate cancer and ...

Doctors in New Hampshire Now Treating Cancer with Non-Invasive Image-Guided Radiosurgery Using Novalis Tx(TM) Technology

... A 71-year old man with inoperable lung cancer is able to receive stereotactic body ... surgery was not an option for removing his lung tumor. To treat the tumor, Arul Mahadevan, MD, ... as much as possible, the delicate healthy lung tissues around it. To further ensure treatment ...

Bayer and Onyx Announce Nexavar Data Presentations at 45th American Society of Clinical Oncology Annual Meeting

... Hall F3 lung Cancer A Phase 2 Study of ... with Locally Advanced/Metastatic Non-Small Cell lung Cancer Joline S. Lind, M.D., ... including breast cancer, colorectal cancer, lung cancer, ovarian cancer, and as an adjuvant ...

New Study Funded By the National Institutes of Health (NIH) Finds Masimo SpCO(R) May Provide a Noninvasive Measure of Acute Asthma Severity in Children

... Association between SpCO and Measures of lung Function IRVINE, Calif., May 13 ... was an associated 79% proportionate decrease in lung function (%FEV1, p=0.015) and a trend indicating SpCO may predict lung function after 2-hours of treatment, as measured ...

Lilly Set to Unveil More Than 50 Studies at ASCO 2009

... "With ASCO studies focusing on non-small cell lung cancer, breast cancer, cervical cancer and ... phase III study in advanced non-small cell lung cancer This study is being presented ... as First-line Therapy for Advanced Non-Small Cell lung Cancer Abstract #8045: ...

Independent Data Monitoring Committee Supports Continuation of Picoplatin Phase 3 SPEAR Registration Trial in Small Cell Lung Cancer

... safety of picoplatin in patients with small cell lung cancer (SCLC) who were refractory to or ... the second half of 2009. About Small Cell lung Cancer SCLC is the most aggressive form of lung cancer and tends to be widespread by the time of ...

Allegro Diagnostics Expands Board and Executive Team

... leader in the field of molecular diagnostics for lung cancer, has announced that Stephen Chubb has ... leader in the field of molecular diagnostics for lung cancer, has announced that Stephen Chubb has ... most effective ways to reduce deaths from lung cancer are to detect it earlier and identify, ...

Cell Therapeutics Presents Corporate Highlights at Invest Northwest Conference

... (NHL) and OPAXIO for treatment of non-small cell lung cancer, including: Shared ... Reviewed OPAXIO data in small cell lung cancer and the status of the ongoing phase III ... of relapsed aggressive NHL, non-small cell lung cancer and ovarian cancer, determinations by ...

Angiotech announces positive results from Bio-Seal(TM) clinical study

... clinical study results for its Bio-Seal(TM) lung Biopsy Tract Plug System at the Society of ... and efficacy of Bio-Seal in patients undergoing lung biopsy procedures and demonstrated a ... improves the existing technology used to diagnose lung cancer by significantly reducing the rates of ...

FDA Approves SYMBICORT(R) for Chronic Obstructive Pulmonary Disease (COPD)

... for millions of Americans with debilitating lung disease WILMINGTON, Del., Feb. 27 ... which found SYMBICORT significantly improved lung function within five minutes of the first dose(1) and sustained that lung function improvement for the duration of the ...

Implicit Licenses Clinical Stage Antibody Program From Lilly

... to develop this promising drug to treat acute lung injury (ALI) caused by a dysregulated immune ... and commercialisation. About Acute lung Injury Acute lung injury (ALI) is a severe inflammatory disease ...

Peregrine Pharmaceuticals' Bavituximab Achieves Primary Endpoint in First Stage of Phase II Lung Cancer Study

... II clinical trial in patients with non-small cell lung cancer (NSCLC). The open-label, Simon two-stage ... promising early results from this pilot Phase II lung cancer trial and will now move forward to ... Good Clinical Practices (GCP) guidelines. lung cancer is a major cause of cancer deaths ...

OncoGenex Provides Update on Two-Year Survival Data from Ongoing Phase 1/2 Clinical Trial of OGX-011 in Non-Small Cell Lung Cancer

... for the treatment of advanced non-small cell lung cancer (NSCLC). At two years, 30% of patients who ... in various cancers." Non-Small Cell lung Cancer Phase 1/2 Study Design with Updated ... undifferentiated or unspecified non-small cell lung cancer. The primary objectives of the study were ...

InterMune Reports Results of Two Phase 3 CAPACITY Studies of Pirfenidone in IPF

... In CAPACITY 2, 83% and 90% of surviving, lung transplant-free patients completed therapy per ... in the overall treatment effect of pirfenidone on lung function and exercise tolerance. In addition, ... IPF patients with mild to moderate impairment in lung function. The primary endpoint of both trials ...

Chronic Lung Disease - Axentis Pharma Attracts Investment Interest

... new therapeutic formulation for treating chronic lung disease at the 2nd Annual European Life Science ... uses biocompatible lipids endogenous to the lung that are formulated into small liposomes. ... increased secretion deposits on mucous membranes. lung complications represent the most serious ...

Rosetta Genomics Announces Exclusive Distribution Agreement With Teva Pharmaceutical Industries Ltd.

... squamous from non-squamous, non-small cell lung cancer (NSCLC) patients. When administered ... patients with squamous cell carcinoma of the lung have demonstrated varying response patterns ... squamous from non-squamous non-small cell lung cancer are not standardized, are difficult to ...

YM BIOSCIENCES RECEIVES CLEARANCE TO INITIATE RANDOMIZED DOUBLE-BLIND CLINICAL TRIALS OF NIMOTUZUMAB IN LUNG CANCER AND BRAIN METASTASES FROM LUNG CANCER

... in approximately 128 patients with non-small cell lung cancer (NSCLC) and a Phase II trial in ... other EGFR-targeting drugs." Non-small cell lung cancer trial This randomized, double-blind, ... among patients with metastatic non-small-cell lung cancer. Int J Radiat Oncol Biol Phys ...

Rosetta Genomics Announces Commercial Availability of Its Third MicroRNA-Based Diagnostic Test: miRview(TM) meso

... from several types of carcinomas in the lung with such high level of accuracy" noted Harvey ... Medical Center. "Ruling out Mesothelioma from lung cancer for individuals that were exposed to ... between two subtypes of non small cell lung cancer (NSCLC). This diagnosis is important ...

38 Cryoablation Studies, Exhibits Presented at National Radiological Society Meeting

... effectiveness of cryoablation for treating liver, lung and brain cancers, as well as an immunologic ... to cryoablation as a treatment for bone pain, lung and kidney cancers, in addition to the more ... the ablation of tumors in the kidney, lung and liver and palliative intervention (treatment ...

China Medical Technologies Completes the Development of EGFR Molecular Diagnostic Kits

... of molecular diagnostic kits for non-small cell lung cancer therapy," said Mr. Xiaodong Wu, ... with significant market potential." lung cancer is one of the most common cancers in the ... China. It is estimated that more than 500,000 new lung cancer cases were diagnosed each year in China ...

NIH Awards Approximately $3M Grant for Research Involving WaferGen's SmartChip(TM) Real-Time PCR System at the University of Pittsburgh

... A Custom Molecular Phenotyping Assay for lung Disease FREMONT, Calif., Oct. 30 ... novel gene expression research in the area of lung disease involving WaferGen's SmartChip(TM) ... M.D., will apply gene expression profiling to lung samples from patients with chronic obstructive ...

New Research Shows Many Patients with Persistent Cough and Sputum Actually had Airway Obstruction Consistent with COPD

... symptoms, smoking history and age. About the lung Function Questionnaire Data was also presented ... States. COPD is a progressive, life- threatening lung disease that includes chronic bronchitis and ... by airflow obstruction, a limitation in lung function that makes it difficult to breathe. Many ...

Unraveling the genetic picture of lung cancer

... pathways activated in the most common form of lung cancer lung adenocarcinoma and could lead to improved ... play a significant role in the development of lung adenocarcinoma as well as cellular pathways ...

Large-scale genetic study sheds new light on lung cancer

... changes involved in the most common form of lung cancer, lung adenocarcinoma. The findings should help pave the ... 26 genes that are frequently mutated in lung adenocarcinoma -- an achievement that more than ...

Peregrine Pharmaceuticals Completes Patient Enrollment In First Stage of Bavituximab Phase II Lung Cancer Trial

... Planned Cohort of 21 Patients with Non-Small Cell lung Cancer Enrolled in First Stage of Trial ... and paclitaxel in patients with non-small cell lung cancer (NSCLC). The primary objective of the ... and Good Clinical Practices (GCP) standards. lung cancer is a major cause of cancer deaths ...

Lilly to Acquire ImClone Systems in $6.5 Billion Transaction

... head and neck, colorectal and non-small cell lung cancer. Given that three of ImClone's pipeline ... therapy Pulmonary Toxicity -- Interstitial lung disease (ILD), which was fatal in one ... treatment of advanced nonsquamous non-small cell lung cancer (NSCLC), a specific type of NSCLC. ALIMTA ...

Pharmaxis Research Programs Highlighted at European Respiratory Society Congress

... symposiums and poster sessions relating to the lung challenge product, Aridol, and the mucus clearing ... for everyday practice -- Infectious lung diseases including tuberculosis -- A ... for important improvements in the treatment of lung diseases. Full details of ERS may be viewed on ...

Transave, Inc. Secures $12.5 Million in New Financing

... for the site-specific treatment of serious lung diseases, today announced that it has secured a ... GmbH), produced a significant improvement in lung function, was well-tolerated, and had a ... in the treatment of Pseudomonas aeruginosa, a lung infection common in cystic fibrosis ....

Researchers develop new model for cystic fibrosis

... of death and disability in patients with CF is lung disease. However, many questions remain about how infection and inflammation leads to lung damage. In the study, the lungs of the newborn CF ... researchers hope to learn more about how and why lung disease develops in patients with CF. ...

Pigs bred with cystic fibrosis provide model to mimic human disease

... disease in Caucasians - often die because of a lung disease developed later. Scientists have been ... develop an animal model that develops the fatal lung disease. Now, a University of Missouri researcher ... continue to mimic the human symptoms so the fatal lung disease can be studied and ultimately treated. ...

33rd ESMO Congress in Stockholm, 12-16 September 2008

... drugs over the past 10 years in 27 countries. lung Cancer Significant benefits in non-small-cell lung cancer from customising treatment (Embargoed until Saturday 13 September 2008, 12:45 CEST) lung cancer patients whose tumours carry specific ...
Other Contents
(Date:9/15/2014)... epilepsy drug to a morphine regimen can result in ... combination can reduce the dosage of the opioid needed ... researchers at Indiana University. , The result could bring ... difficult-to-treat condition often felt in the arms and legs ... a huge unmet need for better treatments for neuropathic ...
(Date:9/15/2014)... When this week,s print issue of the journal ... up from New Mexico, Montana and even the Netherlands, ... more and more the norm in these connected times. ... it will produce innovations in biology, medicine, biotechnology and ... this scientist talked with that one, that one knew ...
(Date:9/15/2014)... A new strategic vision document, released today by ... describes the long-term goals, objectives, and strategies for ... work over the next five years (2015-2020). ... short-term activities, to be funded in 2015, will ... policy fellowships. , The $500 million, 30-year ...
Breaking Biology News(10 mins):IU study: Combining epilepsy drug, morphine can result in less pain, lower opioid doses 2Collaboration drives achievement in protein structure research 2NAS Gulf Research Program announces strategic vision, initial opportunities 2NAS Gulf Research Program announces strategic vision, initial opportunities 3NAS Gulf Research Program announces strategic vision, initial opportunities 4
(Date:9/16/2014)... (PRWEB) September 16, 2014 Magpi, a ... and communication applications, today announced that CEO and ... Count, a cross-sector ideation session focusing on the use ... in New York City on September 23. Dr. Selanikio ... data to provide insights on global health programming and ...
(Date:9/16/2014)... A recent article discusses the ... filler, “Expression”, which has not been approved for cosmetic ... be used as an intra-nasal splint following rhinoplasty, and ... a dermal filler. Because of its low cost, some ... and patients have had bad reactions to it including ...
(Date:9/16/2014)... Oakland, CA (PRWEB) September 16, 2014 ... double-issue journal on cancer and genetics in Cuba. ... and genetics, the two themes are intrinsically connected, since ... cancer-related articles relate to the full spectrum of cancer ... Cubans' shared ancestry is the topic of an ...
(Date:9/16/2014)... NY (PRWEB) September 16, 2014 On ... Champion Danielle Strassle at the 2014 Buffalo Bills Alumni ... Buffalo, NY. , Bills legend and NFL Hall-of-Famer ... assisted the foundation in honoring Strassle for her dedication ... professional goals and inspire others in her community to ...
(Date:9/16/2014)... Online retailer Kettlebell Kings has announced that ... kettlebell purchases in their online store. The company wants ... with this effective workout method that is quickly gaining ... carries a variety of kettlebell brands as well as ... , “We’ve seen for ourselves how effective kettlebells ...
Breaking Medicine News(10 mins):Health News:Magpi CEO and Co-founder Dr. Joel Selanikio to Speak at Health Workers Count, Global Health Session Held during the UN General Assembly 2Health News:FDA Warns Against Non-approved Dermal Filler 2Health News:FDA Warns Against Non-approved Dermal Filler 3Health News:MEDICC Review Journal Dedicates Double Issue to Cancer and Genetics 2Health News:MEDICC Review Journal Dedicates Double Issue to Cancer and Genetics 3Health News:The HearStrong Foundation and the Buffalo Bills Alumni Foundation Celebrated HearStrong Champion During 2014 Alumni Weekend 2Health News:Join the Kettlebell Movement - Kettlebell Kings Announces $0 Shipping on all Orders 2
Other TagsOther Tags